Patent Assignment
Reel/Frame 019670/0324
Assignment of Assignor's Interest
Recorded: 2007-08-08
Pages: 6
Assignors
MCKINNEY, ANTHONY A.
Executed: 2007-07-12
TOLLERSON, GARY D.
Executed: 2007-07-12
SOLTERO, RICHARD
Executed: 2007-08-01
DUNZO, THEA ELISE
Executed: 2007-08-01
Assignee
OREXIGEN THERAPEUTICS, INC.
12481 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO, CALIFORNIA, 92130
Covered Property
(1)
Sustained Release Formulation of Naltrexone
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 11, 2008
From: MCKINNEY, ANTHONY A.; TOLLEFSON, GARY D.; SOLTERO, RICHARD; DUNZO, THEA ELISE
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 021083/0196 →
Security Agreement
Mar 21, 2016
From: OREXIGEN THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 038180/0021 →
Assignment of Assignor's Interest
Aug 2, 2018
From: OREXIGEN THERAPEUTICS, INC.
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 046688/0661 →
Security Interest
Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Release of Security Interest
Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →
Change of Name
Oct 17, 2019
From: NALPROPION PHARMACEUTICALS, INC.
To: NALPROPION PHARMACEUTICALS LLC
Reel/Frame 050750/0497 →
Security Interest
Dec 19, 2019
From: CURRAX PHARMACEUTICALS LLC; NALPROPION PHARMACEUTICALS LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 051377/0958 →